<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03624465</url>
  </required_header>
  <id_info>
    <org_study_id>CP005</org_study_id>
    <nct_id>NCT03624465</nct_id>
  </id_info>
  <brief_title>Prospective Clinical Study of the Levita Magnetics Surgical System Used for Prostatectomy Surgery</brief_title>
  <official_title>Prospective Clinical Study of the Levita Magnetics Surgical System Used for Prostatectomy Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Levita Magnetics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Levita Magnetics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and effectiveness of the Levita Magnetic
      Surgical System in patients undergoing prostatectomy surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, multicenter, single-arm, open label study designed to assess the safety and
      effectiveness of the Levita Magnetic Surgical System in prostatectomy surgery.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 13, 2018</start_date>
  <completion_date type="Anticipated">July 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number and types of tools required to retract the prostate during procedure</measure>
    <time_frame>During planned prostatectomy procudure</time_frame>
    <description>Ability to adequately retract the prostate to achieve an effective exposure of the target tissue. Adequate retraction is achieved if it is not necessary to replace the Levita Magnetic Surgical System with another instrument to retract the prostate during the procedure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of device related adverse events (safety)</measure>
    <time_frame>Through 30 days post prostatectomy procedure.</time_frame>
    <description>All adverse events will be recorded and allocated as to relatedness to device, procedure or other.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Prostatectomy</condition>
  <arm_group>
    <arm_group_label>Levita Magnetic Surgical System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Levita Magnetic Surgical System use of surgical tool</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Levita Magnetic Surgical System</intervention_name>
    <description>Device for use as a surgical tool.</description>
    <arm_group_label>Levita Magnetic Surgical System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is at least 18 years of age

          -  Subject is scheduled to undergo elective prostatectomy surgery

        Exclusion Criteria:

          -  Significant comorbidities

          -  Subjects with pacemakers, defibrillators, or other electromedical implants

          -  Subjects with ferromagnetic implants

          -  Clinical history of impaired coagulation

          -  Subject has an anatomical abnormality noted after initiation of index procedure that
             would prevent device use

          -  Subject is not likely to comply with the follow-up evaluation schedule

          -  Subject is participating in another clinical trial
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew Gettman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fundacion Arturo Lopez Perez (FALP)</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>August 7, 2018</study_first_submitted>
  <study_first_submitted_qc>August 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2018</study_first_posted>
  <last_update_submitted>June 3, 2019</last_update_submitted>
  <last_update_submitted_qc>June 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

